The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,517,043 in first-year total cost, median $4,517,043.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-L (07)]1
Most frequent institutions
- UNIVERSITY OF SOUTHERN CALIFORNIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)1U54NS100064-01 | ENGEL, JEROME NONEGALANOPOULOU, ARISTEA SMOSHE, SOLOMON L.O'BRIEN, TERENCE JOHNPITKANEN, ASLA SLTOGA, ARTHUR WVESPA, PAUL M | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $4,517,043 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.